Keeping Up with the Fellows!

Groundbreaking research is the key to transforming cancer care, improving outcomes for patients and their families. Now more than ever, support for this work is critical. The 2024-2025 KACF Fellows at Memorial Sloan Kettering are leading the charge:

🔬 Dr. Vanja Cabric is exploring how early-life immune development shapes pediatric solid tumors, with a focus on hepatoblastoma and novel immunotherapies.

🧬 Dr. Andrew Hanna is redefining sarcoma classification using genomics and computational biology to uncover new treatment targets.

💊 Dr. Olayode Babatunde is leading clinical trials on innovative therapies for sarcomas, including immunotherapy for cutaneous angiosarcoma.

With continued research and support, we can drive life-changing breakthroughs. Learn more in the mid-year update from MSK here: